Article Versions Notes

Brühlmann SA, Kreller M, Pietzsch H-J, Kopka K, Mamat C, Walther M, Reissig F. Efficient Production of the PET Radionuclide ¹³³La for Theranostic Purposes in Targeted Alpha Therapy Using the ¹³⁴Ba(p,2n)¹³³La Reaction. Pharmaceuticals. 2022; 15(10):1167. https://doi.org/10.3390/ph15101167

Brühlmann, Santiago Andrés, Martin Kreller, Hans-Jürgen Pietzsch, Klaus Kopka, Constantin Mamat, Martin Walther, and Falco Reissig. 2022. "Efficient Production of the PET Radionuclide ¹³³La for Theranostic Purposes in Targeted Alpha Therapy Using the ¹³⁴Ba(p,2n)¹³³La Reaction" Pharmaceuticals 15, no. 10: 1167. https://doi.org/10.3390/ph15101167

Brühlmann, S. A., Kreller, M., Pietzsch, H.-J., Kopka, K., Mamat, C., Walther, M., & Reissig, F. (2022). Efficient Production of the PET Radionuclide ¹³³La for Theranostic Purposes in Targeted Alpha Therapy Using the ¹³⁴Ba(p,2n)¹³³La Reaction. Pharmaceuticals, 15(10), 1167. https://doi.org/10.3390/ph15101167